Kazia Therapeutics (KZIA) Revenue & Revenue Breakdown
Kazia Therapeutics Revenue Highlights
Latest Revenue (Y)
$555.00
Latest Revenue (Q)
$5.00
Main Segment (Y)
Licensing Revenue
Main Geography (Y)
CHINA
Kazia Therapeutics Revenue by Period
Kazia Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-06-30 | $555.00 | 2120.00% |
| 2022-06-30 | $25.00 | -100.00% |
| 2021-06-30 | $15.18M | 1430881.24% |
| 2020-06-30 | $1.06K | -32.20% |
| 2019-06-30 | $1.56K | -88.06% |
| 2018-06-30 | $13.11K | -99.85% |
| 2017-06-30 | $8.79M | 115.87% |
| 2016-06-30 | $4.07M | 4474.16% |
| 2015-06-30 | $89.00K | 2.30% |
| 2014-06-30 | $87.00K | -91.85% |
| 2013-06-30 | $1.07M | -56.44% |
| 2012-06-30 | $2.45M | 20.99% |
| 2011-06-30 | $2.02M | -79.56% |
| 2010-06-30 | $9.91M | -11.12% |
| 2009-06-30 | $11.15M | -16.03% |
| 2008-06-30 | $13.28M | -23.33% |
| 2007-06-30 | $17.31M | 28.21% |
| 2006-06-30 | $13.50M | -23.30% |
| 2005-06-30 | $17.61M | 7.71% |
| 2004-06-30 | $16.35M | -50.36% |
| 2003-06-30 | $32.93M | 68.06% |
| 2002-06-30 | $19.59M | -66.74% |
| 2001-06-30 | $58.91M | 120.27% |
| 2000-06-30 | $26.75M | 38.41% |
| 1999-06-30 | $19.32M | - |
Kazia Therapeutics generated $555.00 in revenue during NA 2023, up 2120.00% compared to the previous quarter, and up 4.23% compared to the same period a year ago.
Kazia Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $5.00 | -99.10% |
| 2023-06-30 | $555.00 | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | -100.00% |
| 2022-06-30 | $-2.90M | 100.00% |
| 2022-03-31 | - | -100.00% |
| 2021-12-31 | $10.00K | 100.00% |
| 2021-09-30 | $5.00K | -99.97% |
| 2021-06-30 | $15.18M | 1297467.61% |
| 2020-12-31 | $1.17K | -99.68% |
| 2020-06-30 | $362.43K | 100.00% |
| 2020-03-31 | $181.21K | -71.04% |
| 2019-12-31 | $625.68K | 100.00% |
| 2019-09-30 | $312.84K | -53.43% |
| 2019-06-30 | $671.76K | 100.00% |
| 2019-03-31 | $335.88K | -56.28% |
| 2018-12-31 | $768.24K | 100.00% |
| 2018-09-30 | $384.12K | -75.30% |
| 2018-06-30 | $1.55M | 100.00% |
| 2018-03-31 | $777.45K | -46.36% |
| 2017-12-31 | $1.45M | 100.00% |
| 2017-09-30 | $724.65K | -82.75% |
| 2017-06-30 | $4.20M | -8.39% |
| 2016-12-31 | $4.59M | 1842.73% |
| 2016-06-30 | $236.09K | 100.00% |
| 2016-03-31 | $118.04K | -96.11% |
| 2015-12-31 | $3.04M | 100.00% |
| 2015-09-30 | $1.52M | 1075.31% |
| 2015-06-30 | $129.15K | 100.00% |
| 2015-03-31 | $64.57K | -95.94% |
| 2014-12-31 | $1.59M | -45.16% |
| 2008-06-30 | $2.90M | -18.15% |
| 2008-03-31 | $3.54M | 3.68% |
| 2007-12-31 | $3.41M | -0.05% |
| 2007-09-30 | $3.42M | 0.00% |
| 2007-06-30 | $3.42M | 0.35% |
| 2007-03-31 | $3.40M | -35.16% |
| 2006-12-31 | $5.25M | 0.25% |
| 2006-09-30 | $5.24M | 115.86% |
| 2006-06-30 | $2.43M | -0.27% |
| 2006-03-31 | $2.43M | -43.75% |
| 2005-12-31 | $4.33M | -0.02% |
| 2005-09-30 | $4.33M | -40.03% |
| 2005-06-30 | $7.21M | 137.55% |
| 2005-03-31 | $3.04M | -36.74% |
| 2004-12-31 | $4.80M | 0.10% |
| 2004-09-30 | $4.79M | 4.85% |
| 2004-06-30 | $4.57M | 11.69% |
| 2004-03-31 | $4.09M | -0.39% |
| 2003-12-31 | $4.11M | -0.04% |
| 2003-09-30 | $4.11M | -78.42% |
| 2003-06-30 | $19.05M | 288.00% |
| 2003-03-05 | $4.91M | 0.03% |
| 2002-12-31 | $4.91M | 0.01% |
| 2002-09-30 | $4.91M | 0.62% |
| 2002-06-30 | $4.88M | -0.53% |
| 2002-03-31 | $4.90M | 0.14% |
| 2001-12-31 | $4.90M | 0.02% |
| 2001-09-30 | $4.90M | -60.59% |
| 2001-06-30 | $12.42M | -19.83% |
| 2001-03-31 | $15.50M | 14.85% |
| 2000-12-31 | $13.49M | -2.53% |
| 2000-09-30 | $13.84M | -751.15% |
| 2000-06-30 | $-2.13M | -122.09% |
| 2000-03-31 | $9.62M | 7.59% |
| 1999-12-31 | $8.95M | -0.27% |
| 1999-09-30 | $8.97M | - |
Kazia Therapeutics generated $5.00 in revenue during Q2 2024, up -99.10% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Kazia Therapeutics Revenue Breakdown
Kazia Therapeutics Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Jun 24 | Jun 21 |
|---|---|---|
| Licensing Revenue | $2.30M | $15.18M |
Latest
Kazia Therapeutics's latest annual revenue breakdown by segment (product or service), as of Jun 24: Licensing Revenue (100.00%).
Kazia Therapeutics Revenue Breakdown by Country
Annual Revenue by Country
| Country | Jun 21 |
|---|---|
| CHINA | $10.01M |
| Swedan | $5.18M |
Latest
Kazia Therapeutics's latest annual revenue breakdown by geography, as of Jun 21: CHINA (65.90%), and Swedan (34.10%).
Kazia Therapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| CTMX | CytomX Therapeutics | $101.21M | $33.43M |
| SPRO | Spero Therapeutics | $96.73M | $13.47M |
| NRIX | Nurix Therapeutics | $76.99M | $12.59M |
| OCUL | Ocular Therapeutix | $58.44M | $14.71M |
| SEER | Seer | $16.66M | $4.03M |
| MREO | Mereo BioPharma Group | $10.00M | - |
| ASMB | Assembly Biosciences | $7.16M | $6.84M |
| HCWB | HCW Biologics | $2.84M | $426.42K |
| QSI | Quantum-Si | $1.08M | $787.00K |
| MNOV | MediciNova | $1.00M | - |
| KZIA | Kazia Therapeutics | $555.00 | $5.00 |
| NLSP | NLS Pharmaceutics | - | - |
| ANEB | Anebulo Pharmaceuticals | - | - |
| DAWN | Day One Biopharmaceuticals | - | $20.07M |
| RNXT | RenovoRx | - | - |
| OKYO | OKYO Pharma | - | - |
| ACHL | Achilles Therapeutics | - | - |
| CADL | Candel Therapeutics | - | - |
| SLS | SELLAS Life Sciences Group | - | - |
| QNRX | Quoin Pharmaceuticals | - | - |
| KTTA | Pasithea Therapeutics | - | - |